SELECTIVE BIFUNCTIONAL DRUG ON THE BASIS OF FRAGMENTS OF CAMEL SINGLE-CHAIN ANTIBODIES, AIMED ON TUMOR RECEPTORS CD47/CD44, INTENDED FOR THERAPY OF MALIGNANT NEOPLASMS Russian patent published in 2018 - IPC C07K16/46 A61K39/395 C12N15/13 

Abstract RU 2658764 C1

FIELD: biotechnology.

SUBSTANCE: selective bifunctional protein complex is proposed that suppresses growth and/or causes apoptosis of cancer stem cells, consisting of two fragments of the variable parts of VHH-camel antibodies, capable of recognizing and selectively binding to the CD47 and CD44 cellular receptors, where the fragments are linked together into a single polypeptide chain by a polypeptide linker.

EFFECT: this complex possesses a high specificity, bioavailability, and, in comparison with traditional monoclonal antibodies, highly effective and selectively affects cancer stem cells, while having a minimal effect on the normal cells of the patient's body.

1 cl, 2 ex

Similar patents RU2658764C1

Title Year Author Number
SELECTIVE BIFUNCTIONAL DRUG ON THE BASIS OF FRAGMENTS OF CAMELIZED SINGLE-CHAIN ANTIBODIES, AIMED TO ONCOTIC RECEPTORS CD47/ERBB2, INTENDED FOR THE THERAPY OF MALIGNANT NEOPLASMS 2016
  • Chumakov Stepan Petrovich
  • Kravchenko Yuliya Evgenevna
  • Ratnikova Natalya Mikhajlovna
  • Frolova Elena Ivanovna
RU2648164C1
NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER 2020
  • Gorchakov Andrej Aleksandrovich
  • Kulemzin Sergej Viktorovich
  • Chikaev Anton Nikolaevich
  • Taranin Aleksandr Vladimirovich
RU2757353C1
USE OF O-ACETYLATED GD2 GANGLIOSIDE AS TARGET AS NOVEL THERAPEUTIC AND DIAGNOSTIC APPROACH IN MALIGNANT GROWTHS CONTAINING TUMOUR STEM CELLS 2014
  • Birkl Stefan
  • Koshonno Deni
  • Dorvijyu Milen
  • Le Dussal Zhan-Mark
  • Term Mikael
RU2702428C2
GENETIC CONSTRUCT CODING STRUCTURE OF T-CELL CHIMERIC RECEPTOR BASED ON SINGLE-CHAIN VHH ANTIBODIES SPECIFIC TO TUMOUR RECEPTOR CD47 FOR THE TARGETED IMMUNOTHERAPY OF MALIGNANT GROWTHS 2017
  • Chumakov Stepan Petrovich
  • Kravchenko Yuliya Evgenevna
  • Kravchenko Dmitrij Sergeevich
  • Frolova Elena Ivanovna
RU2707535C2
DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS 2014
  • Sakhin Ugur
  • Tyurechi Ozlem
  • Valter Korden
  • Vagner Majke
  • Krojtsberg Mariya
  • Kheker Sabine
  • Yakobs Shtefan
RU2749867C2
RECOMBINANT STRAIN OF HERPESVIRUS SAIMIRI FOR OBTAINING POPULATIONS OF IMMORTALISED AUTOLOGOUS T LYMPHOCYTES EXPRESSING PAIRED CHIMERIC RECEPTORS AGAINST CD44 AND CD133 TUMOUR ANTIGENS 2020
  • Chumakov Stepan Petrovich
  • Kravchenko Iuliia Evgenevna
  • Kravchenko Dmitrii Sergeevich
  • Frolova Elena Ivanovna
RU2771081C2
ANTIBODIES SPECIFIC TO TUMOUR AND USE THEREOF 2011
  • Makerdzhi Pinku
RU2595403C2
COMPOSITIONS AND METHODS OF IMMUNOTHERAPY 2014
  • Brentdzhens Rener Dzh.
  • Dzhekson Kholli Dzh.
RU2680010C2
ANTIBODIES AGAINST CCR7 RECEPTOR FOR CANCER TREATMENT 2006
  • Mun'Os Kall'Ekha Sesilija
  • Al'Fonso Peres Manuehl' Khesus
  • Lopes Khiral' Sonia
RU2404808C2
AGENTS LINKING FRIZZLED RECEPTOR AND THEIR USE 2009
  • Garni Ostin L.
  • Sato Aaron Ken
  • Akselrod Fumiko Takada
  • Khoej Timoti Charlz
  • Satjal Sandzhiv Kh.
  • Mitra Satjadzhit Sudzhit Kumar
RU2579897C2

RU 2 658 764 C1

Authors

Chumakov Stepan Petrovich

Kravchenko Yuliya Evgenevna

Ratnikova Natalya Mikhajlovna

Frolova Elena Ivanovna

Dates

2018-06-22Published

2016-12-19Filed